Zepbound Coupon Update 2026: What's New, What Changed, and How to Use the Latest Savings Programs

Key Takeaways

• The 2026 Zepbound Savings Card keeps the $25 price for commercially insured patients whose plan covers Zepbound, but the cap fell to $100 per 1-month fill ($200 per 2-month, $300 per 3-month) and $1,300 per calendar year, from $150 and $1,950 in 2025; 13 fills a year; the card expires December 31, 2026 (zepbound.lilly.com, seen September 5, 2026).
• For commercially insured patients whose plan does not cover Zepbound, the price fell: $499 for a 1-month single-dose pen fill, or $299 for the 2.5 mg KwikPen, versus $650 under the 2025 card.
• LillyDirect self-pay prices are $299 (2.5 mg), $399 (5 mg) and $449 (7.5 to 15 mg) for vials or the KwikPen when you refill within 45 days; the regular price is $499 for 7.5 mg and $699 for 10, 12.5 and 15 mg. The KwikPen launched February 23, 2026.
• Medicare, Medicaid, TRICARE, VA and DoD beneficiaries remain excluded from the card, but Medicare now has its own route: the Medicare GLP-1 Bridge, $50 a month for the Zepbound KwikPen with prior authorization, July 1, 2026 to December 31, 2027.
• Correction, September 2026: earlier versions of this page described a Tier 2 increase to $650, a $469 per-fill cap, flat $349 and $499 LillyDirect prices, a $1,499 three-month bundle and free 2-day shipping. None of that is in Lilly's 2026 terms; it has been replaced with the sourced figures on this page.

The short answer

As of September 5, 2026, the 2026 Zepbound Savings Card gives commercially insured patients whose plan covers Zepbound a $25 price, with the card paying up to $100 per 1-month fill and $1,300 per calendar year across 13 fills (down from $150 and $1,950 in 2025); the card expires December 31, 2026. Commercially insured patients whose plan does not cover Zepbound pay $499 for a 1-month single-dose pen fill or $299 for the 2.5 mg KwikPen, down from $650. LillyDirect self-pay is $299, $399 or $449 by dose with a refill within 45 days. Medicare enrollees are still excluded from the card but can use the Medicare GLP-1 Bridge: $50 a month for the Zepbound KwikPen from July 1, 2026 to December 31, 2027.

Table of contents

1. The 30-second answer
2. What changed in the 2026 Zepbound coupon update
3. What stayed the same
4. New LillyDirect doses and bundle options
5. How the update affects current Zepbound patients
6. Predicted future changes through 2027
7. How to verify your current price at the pharmacy
8. The compounded tirzepatide path for excluded patients
9. What actually changed for 2026
10. Medicare: the $50 GLP-1 Bridge
11. Annual cost scenarios, recomputed
12. FAQ
13. Sources
14. Footer disclaimers

What changed in the 2026 Zepbound coupon update

Here is the 2025-to-2026 delta from Lilly's published terms (savings card terms at zepbound.lilly.com and the LillyDirect Journey program terms, both seen September 5, 2026; 2025 terms per the 2025 card as documented by On The Pen, October 28, 2024).

1. The not-covered price went down, not up. Commercially insured patients whose plan does not cover Zepbound paid $650 a month under the 2025 card (for cards issued after August 28, 2024). In 2026 the card price is $499 for a 1-month single-dose pen fill, and $299 for the 2.5 mg Zepbound KwikPen.

2. The covered-benefit cap fell. The 2025 card covered up to $150 per month and $1,950 per year. The 2026 card covers up to $100 per 1-month fill, $200 per 2-month fill and $300 per 3-month fill, with a $1,300 calendar-year maximum. If your covered copay is $125 or less you pay $25; a $500 copay comes down to $400, not $25.

3. The 13-fill limit held, and a new self-pay track appeared. The covered-benefit card still allows up to 13 fills per calendar year. The self-pay KwikPen program allows up to 11 fills per calendar year. Correction, September 2026: an earlier version quoted 'industry analysts' predicting a cut to 11 or 12 fills; no such analysts were cited and the sentence has been removed.

What stayed the same

The 2026 update kept most program features intact.

Tier 1 minimum copay: still $25. The headline number that most patients see hasn't changed. Patients with commercial insurance that covers Zepbound still pay as little as $25 per fill, subject to the $100 per 1-month cap.

13-fill annual limit. Same as 2024 and 2025. The counter resets each January 1.

Eligibility rules. The card is not valid for patients enrolled in Medicaid, Medicare (any part), DoD, VA or TRICARE, or any state or federal government-funded prescription program. Massachusetts and California are not blanket exclusions: the terms void the card in Massachusetts only where an AB-rated generic equivalent is available and in California where a therapeutic equivalent is available, and no generic tirzepatide exists. Same age requirement (18 and older) and valid prescription requirement. Correction, September 2026: an earlier version listed Massachusetts residents and 'some' federal employee plans as excluded; that misread the terms.

Application process. Same online enrollment at zepbound.lilly.com. Same card format with Member ID, BIN, PCN, and Group number.

LillyDirect prices. Not flat: 2026 self-pay prices are $299 (2.5 mg), $399 (5 mg) and $449 (7.5 to 15 mg) with a refill within 45 days, otherwise $499 (7.5 mg) and $699 (10 to 15 mg). Correction, September 2026: the earlier $349 and $499 figures were wrong for 2026.

Stacking rules. Still can't combine the savings card with GoodRx or other discount cards. Still can pay residual amounts using FSA or HSA funds.

Most covered patients with modest copays will not notice the 2026 change; patients with high copays and the not-covered group will.

New LillyDirect doses and bundle options

The real 2026 LillyDirect change is the Zepbound KwikPen, a multi-dose pen launched February 23, 2026 at the same self-pay prices as the vials (CNBC, February 23, 2026; Lilly Journey program terms). Correction, September 2026: this section previously described a three-month $1,499 bundle, free expedited 2-day shipping, a 50-state provider network and a mid-2025 launch date for the 12.5 mg vial. None of those appear in Lilly's terms or announcements, and they have been removed.

Zepbound KwikPen. Each KwikPen holds 10 mg in 2.4 mL and delivers four weekly doses (Zepbound prescribing information, revised August 2026). Per the Journey program terms, one month is 28 days, meaning four vials or one KwikPen.

All strengths at set prices. $299 (2.5 mg), $399 (5 mg) and $449 (7.5, 10, 12.5 and 15 mg) when refilled within 45 days of the prior fill; the regular price without that refill is $499 for 7.5 mg and $699 for 10, 12.5 and 15 mg.

Medicare link. LillyDirect's Zepbound page links Medicare patients to the Medicare GLP-1 Bridge for the KwikPen.

Full terms are at lilly.com/lillydirect/zepbound (seen September 5, 2026).

How the update affects current Zepbound patients

The 2026 update shakes out differently depending on which path you're on.

If your commercial insurance covers Zepbound: your price is still $25 if your copay is $125 or less; above that, the $100 cap means you pay the difference. The annual limit is still 13 fills and $1,300 in savings. Verify on your first 2026 claim that the card processed.

If you're commercially insured and Zepbound is not covered: your card price fell from $650 to $499 for a 1-month single-dose pen fill, or $299 for the 2.5 mg KwikPen. Twelve pen fills a year is $5,988. Correction, September 2026: the earlier '$8,450' figure on this page was built on the wrong price.

If you're on LillyDirect (no insurance or government coverage): $299, $399 or $449 a month depending on dose, with the 45-day refill condition; $499 or $699 without it.

If you're on Medicare: the savings card still excludes you, but the Medicare GLP-1 Bridge caps the Zepbound KwikPen at $50 a month with prior authorization from July 1, 2026 through December 31, 2027, outside the $2,100 Part D cap. Medicaid patients remain excluded from the card and are not part of the Bridge; LillyDirect self-pay is the remaining brand route.

If you used all 13 fills in 2025: You started fresh on January 1, 2026. The new fill counter resets, and your Tier 1 or Tier 2 path applies.

The biggest change for out-of-pocket payers is that the not-covered card price ($499) and LillyDirect ($299 to $449) now sit close together, and the Medicare Bridge undercuts both at $50.

Predicted future changes through 2027

Correction, September 2026: this section previously predicted a Tier 2 increase to $700 to $750 and other 2027 changes. Those predictions were built on the false premise that the price rose in 2026, and they have been removed. What is written down: the 2026 card expires December 31, 2026; Lilly publishes new terms each January; the Medicare GLP-1 Bridge runs through December 31, 2027.

Check zepbound.lilly.com for current terms.

How to verify your current price at the pharmacy

After the 2026 update, the safest way to confirm your price is to ask the pharmacy to run a test claim before your fill.

Step 1. Call your local pharmacy or use the pharmacy's app (Walmart, CVS, Costco, etc.).

Step 2. Ask the pharmacist to run a "test claim" or "trial adjudication" for your Zepbound prescription using your insurance card and your Zepbound Savings Card details.

Step 3. The pharmacist returns three prices: your insurance copay (without the card), your insurance copay with the card applied, and your final out-of-pocket. Most patients see $25 (covered, copay up to $125), $499 or $299 (not covered, pen or 2.5 mg KwikPen), or $50 (Medicare Bridge, KwikPen).

Step 4. If the number doesn't match what you expect, the most common issues are: card number entered wrong, prescription written for Mounjaro instead of Zepbound, prior authorization not yet approved, or insurance plan changed since last fill.

Step 5. If insurance is the issue (e.g., a new prior auth requirement), you have options: get the prior auth, switch to LillyDirect for the month, or use a different pharmacy network.

This 5-minute check before each fill prevents the most common sticker shock at the counter.

The compounded tirzepatide path for excluded patients

Patients excluded from the card (Medicaid, VA, TRICARE, DoD, and Medicare patients who cannot use the Bridge) and uninsured patients often look at compounded tirzepatide as a cost alternative.

Compounded pricing, from the FormBlends Compounded GLP-1 Price Index (as of September 3, 2026):

• Compounded tirzepatide, month 1 at 2.5 mg per week: median $299 per 28 days across 14 providers (range $149 to $470)
• Compounded tirzepatide, month 4 at 5 mg per week: median $299 per 28 days across 11 providers (range $179 to $627)

See the Compounded GLP-1 Price Index for methodology and the provider list.

Compounded vs Zepbound savings card:

Path	Monthly cost	Format	FDA approval
Zepbound + savings card, commercial plan covers it	$25 (card pays up to $100 per 1-month fill; $1,300 per year; 13 fills)	Pen, vial or KwikPen	Yes
Zepbound + savings card, commercial plan does not cover it	$499 (1-month single-dose pen fill) or $299 (2.5 mg KwikPen)	Pen or KwikPen	Yes
Zepbound LillyDirect self-pay, 2.5 mg	$299	Vial or KwikPen	Yes
Zepbound LillyDirect self-pay, 5 mg	$399	Vial or KwikPen	Yes
Zepbound LillyDirect self-pay, 7.5 to 15 mg	$449 with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10 to 15 mg)	Vial or KwikPen	Yes
Zepbound KwikPen, Medicare GLP-1 Bridge (July 1, 2026 to December 31, 2027)	$50 with prior authorization	KwikPen	Yes
Compounded tirzepatide (Price Index median, September 3, 2026)	$299 per 28 days at 2.5 mg (range $149 to $470); $299 at 5 mg (range $179 to $627)	Vial	No

At the 2.5 mg starting dose the compounded median ($299) equals the LillyDirect price; at higher doses the Index median stays at $299 while LillyDirect rises to $399 and $449. The trade-off is FDA approval status. Compounded medications haven't gone through the FDA's approval process and aren't interchangeable with branded Zepbound.

For Medicare patients the $50 Bridge is now the least expensive brand route; for Medicaid and other excluded patients, compounded tirzepatide and LillyDirect are the remaining options. For more, see our compounded vs brand-name guide.

How the 2026 update affects new patients starting Zepbound

If you're starting Zepbound for the first time in 2026, the program experience differs from prior years.

Onboarding flow (2026):

1. Get a Zepbound prescription from a licensed provider.
2. Visit zepbound.lilly.com to enroll in the savings card or LillyDirect, depending on your insurance status.
3. If commercial insurance covers Zepbound, fill at any retail pharmacy with the savings card. Tier 1 ($25) applies.
4. If commercial insurance doesn't cover Zepbound, the card price is $499 (pen) or $299 (2.5 mg KwikPen) at retail; LillyDirect self-pay is $299 to $449.
5. If you have Medicare, ask about the GLP-1 Bridge ($50 KwikPen, prior authorization). If you have Medicaid or no insurance, LillyDirect or compounded alternatives are the options.

Things new patients should know:

• The savings card requires a Zepbound prescription, not Mounjaro. The two drugs are the same molecule but different brand-name approvals.
• LillyDirect requires a separate enrollment from the savings card. They're two different programs.
• Prior authorization timelines vary by plan; start early.
• The 13-fill and $1,300 annual limits apply per calendar year; the current card expires December 31, 2026, and Lilly issues new terms each January.

The 2026 update doesn't change the fundamental onboarding process. The financial outcome at the end depends on insurance status, which is the same as it's been since the program launched.

What actually changed for 2026, side by side

Term	2025 card	2026 card (as of September 5, 2026)
Covered by commercial insurance: your price	$25	$25
Covered: maximum card benefit per fill	$150 per month	$100 per 1-month fill; $200 per 2-month; $300 per 3-month
Covered: annual maximum	$1,950	$1,300 per calendar year
Fills per year (covered card)	13	13
Commercial insurance does not cover Zepbound	$650 (cards issued after August 28, 2024; $550 grandfathered to June 30, 2025)	$499 per 1-month single-dose pen fill; $299 for the 2.5 mg KwikPen
Self-pay KwikPen program fills per year	Not applicable	Up to 11
LillyDirect self-pay	Vials only	Vials or KwikPen (from February 23, 2026): $299 (2.5 mg), $399 (5 mg), $449 (7.5 to 15 mg) with a refill within 45 days; otherwise $499 (7.5 mg), $699 (10 to 15 mg)
Medicare	Excluded	Excluded from the card; Medicare GLP-1 Bridge $50 a month for the KwikPen, July 1, 2026 to December 31, 2027
Card expiration	December 31, 2025	December 31, 2026

Sources: zepbound.lilly.com coverage and savings pages and the LillyDirect Journey program terms (seen September 5, 2026); the 2025 column follows the 2025 card terms as documented by On The Pen (October 28, 2024).

Medicare: the $50 GLP-1 Bridge (July 1, 2026 to December 31, 2027)

The savings card excludes Medicare enrollees, and that has not changed. What is new is a federal program rather than a coupon. Under the Medicare GLP-1 Bridge, Medicare patients pay no more than $50 a month for Wegovy, the Zepbound KwikPen or Foundayo, with prior authorization, from July 1, 2026 through December 31, 2027; the cost sits outside the $2,100 Part D out-of-pocket cap (healthinsurance.org, 2026; Lilly's coverage page states 'no more than $50/month'). Note the format: the Bridge covers the KwikPen, not the single-dose pen or vial. LillyDirect's Zepbound page links Medicare patients to the Bridge.

Annual cost scenarios, recomputed

Correction, September 2026: earlier versions of this page computed annual costs from a $650 not-covered price and $349 to $499 LillyDirect prices. Recomputed from the terms seen September 5, 2026, assuming twelve monthly fills where the program allows it:

• Covered, savings card: $25 x 12 = $300 (13 fills permitted; the card pays up to $1,300 for the year).
• Not covered, savings card, single-dose pen: $499 x 12 = $5,988.
• Not covered or self-pay, 2.5 mg KwikPen: $299 x 12 = $3,588 (self-pay program allows up to 11 fills a year).
• LillyDirect, 5 mg: $399 x 12 = $4,788; 7.5 to 15 mg with refills within 45 days: $449 x 12 = $5,388.
• Medicare GLP-1 Bridge, KwikPen: $50 x 12 = $600.
• Compounded tirzepatide at the Price Index median: $299 x 12 = $3,588 (median as of September 3, 2026; not FDA approved).

FAQ

What's the latest Zepbound coupon update for 2026?

For 2026 the covered price stays $25 but the card's cap fell to $100 per 1-month fill and $1,300 per year (13 fills; expires December 31, 2026); the not-covered price fell to $499 for a pen fill or $299 for the 2.5 mg KwikPen; LillyDirect is $299, $399 or $449 by dose; and Medicare patients gained the $50 GLP-1 Bridge from July 1, 2026 (Lilly terms, seen September 5, 2026).

Did the Zepbound savings card price change in 2026?

Yes. The covered price is still $25, but the card now pays at most $100 per 1-month fill (versus $150 in 2025) and $1,300 per year (versus $1,950). The not-covered price fell from $650 to $499 for a single-dose pen fill, with the 2.5 mg KwikPen at $299. Patients whose covered copay is $125 or less will not notice the change.

Is the Zepbound coupon still $25 in 2026?

Yes, for patients with commercial insurance that covers Zepbound: $25 per 1-month fill, up to 13 fills and $1,300 in savings per calendar year, through December 31, 2026. The per-fill cap is $100, so anyone whose copay exceeds $125 pays more than $25 ($400 on a $500 copay).

What's the new Zepbound self-pay price?

$499 for a 1-month single-dose pen fill, or $299 for the 2.5 mg KwikPen, for patients with commercial insurance whose plan does not cover Zepbound. LillyDirect self-pay is $299 (2.5 mg), $399 (5 mg) and $449 (7.5 to 15 mg) for vials or the KwikPen with a refill within 45 days, otherwise $499 to $699 (seen September 5, 2026).

Did Medicare patients gain access to the Zepbound coupon in 2026?

Not to the coupon, which still excludes Medicare, but Medicare patients gained a separate route: the Medicare GLP-1 Bridge, a CMS program that caps the Zepbound KwikPen at $50 a month with prior authorization from July 1, 2026 to December 31, 2027, outside the $2,100 Part D cap (healthinsurance.org; zepbound.lilly.com).

Is there a new LillyDirect bundle in 2026?

No. Correction, September 2026: an earlier version of this page described a $1,499 three-month LillyDirect bundle; no such bundle exists in Lilly's terms, which define one month as 28 days (four vials or one KwikPen). The 2026 LillyDirect change is the KwikPen, launched February 23, 2026 at $299 to $449.

Will the Zepbound coupon get more restrictive in 2027?

Unknown. The 2026 card expires December 31, 2026 and Lilly publishes new terms each January. Correction, September 2026: an earlier answer predicted increases based on an 18 percent 2026 rise that did not happen; the not-covered price fell from $650 to $499.

Does the 2026 coupon update apply automatically?

Yes. Patients who registered in 2025 don't need to reapply. The 2026 program reuses the same Member ID, BIN, PCN, and Group codes. Just verify your card status at zepbound.lilly.com if you're unsure.

Can I still use my 2025 Zepbound coupon in 2026?

The 2026 terms state that the card expires and savings end on December 31, 2026, and 2026 terms (the $100 monthly cap, $1,300 annual cap and $499 or $299 not-covered prices) apply to any 2026 fill. Check your card status at zepbound.lilly.com.

Did LillyDirect prices change in 2026?

Yes. As of September 5, 2026 LillyDirect lists $299 (2.5 mg), $399 (5 mg) and $449 (7.5 to 15 mg) with a refill within 45 days, otherwise $499 to $699, for vials or the KwikPen (launched February 23, 2026). Correction, September 2026: the earlier $349 and $499 figures were wrong.

Should I switch from Tier 2 to LillyDirect after the 2026 update?

Compare $499 (card, not covered, pen) or $299 (card, 2.5 mg KwikPen) with LillyDirect's $299 to $449. LillyDirect does not run insurance claims, so the spend does not count toward your deductible. Talk to your provider before switching.

What if my commercial plan changes its Zepbound coverage mid-2026?

If your plan starts covering Zepbound mid-year, you move to the $25 covered benefit (with the $100 cap) immediately. If your plan drops coverage, you move to the $499 not-covered pen price or $299 KwikPen price, or to LillyDirect. The card adapts to your current insurance status at each fill.

How much is Zepbound with Medicare in 2026?

Through the Medicare GLP-1 Bridge, no more than $50 a month for the Zepbound KwikPen with prior authorization, from July 1, 2026 through December 31, 2027, outside the $2,100 Part D cap (healthinsurance.org; zepbound.lilly.com, seen September 5, 2026). The Zepbound Savings Card itself still excludes anyone enrolled in Medicare, so the Bridge, not the coupon, is the Medicare route.

What is the Zepbound KwikPen price without insurance?

Through LillyDirect the KwikPen costs $299 for 2.5 mg, $399 for 5 mg and $449 for 7.5, 10, 12.5 and 15 mg when you refill within 45 days of your last fill; without that refill the regular price is $499 for 7.5 mg and $699 for the higher strengths (Lilly Journey program terms, seen September 5, 2026). GoodRx listed the KwikPen at $299 at major chains the same day. The pen launched February 23, 2026.

Related guides

• The Zepbound Savings Card in 2025: How It Worked, What Changed for 2026, and How to Use It Today
• Zepbound Coupon Update: April 2026 Savings Card Changes, Eligibility Rules, and Real Patient Costs
• The Zepbound Manufacturer Coupon Explained: Who Qualifies, How Much You Save, and How to Use It at the Pharmacy
• Zepbound Coupon 2025: What the Programs Looked Like Last Year and What's Active in 2026
• Zepbound Coupon 2026: How the Lilly Savings Card Works, Who Qualifies, and What You'll Actually Pay
• Zepbound Manufacturer Coupon 2026: Complete Eligibility Guide and Savings Breakdown
• Tool: cost calculator

Sources

1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216.
2. Eli Lilly and Company. Zepbound (tirzepatide) prescribing information, revised 08/2026. https://pi.lilly.com/us/zepbound-uspi.pdf
3. Eli Lilly. Zepbound Savings Card 2026 terms and conditions (coverage and savings page), accessed September 5, 2026. https://zepbound.lilly.com/coverage-savings
4. CNBC. Eli Lilly launches Zepbound KwikPen with one-month doses at $299 to $449 self-pay, February 23, 2026. https://www.cnbc.com/2026/02/23/eli-lilly-launches-zepbound-obesity-drug-pen-one-month-doses.html
5. CMS Office of Inspector General. Special advisory bulletin: pharmaceutical manufacturer copayment coupons. 2014.
6. Massachusetts General Laws Chapter 175H, Section 3 (manufacturer coupon restrictions). 2012.
7. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for chronic weight management (SURMOUNT-2). Lancet. 2023;402:613-626.
8. Aronne LJ, Sattar N, Horn DB, et al. Tirzepatide for chronic weight management (SURMOUNT-3, lifestyle-induced). JAMA. 2024;331:38-48.
9. Eli Lilly. Zepbound savings page (not-covered price $499 per 1-month single-dose pen fill; $299 KwikPen; self-pay program up to 11 fills per year), accessed September 5, 2026. https://zepbound.lilly.com/savings
10. Eli Lilly. LillyDirect Zepbound pricing ($299, $399, $449 with refill within 45 days; regular $499 and $699), accessed September 5, 2026. https://www.lilly.com/lillydirect/zepbound
11. Eli Lilly. Zepbound Self-Pay Journey Program purchase offer, full terms and conditions ($449 offer beginning February 23, 2026; one month = 28 days = four vials or one KwikPen), accessed September 5, 2026. https://www.lilly.com/lillydirect/medicines/zepbound/self-pay-journey-program-purchase-offer-full-terms-conditions
12. On The Pen. Zepbound Savings Card 2025 released: what you need to know, October 28, 2024 (2025 terms: $150 monthly cap, $1,950 annual cap, $650 not-covered price for post-August 28, 2024 enrollees). https://www.onthepen.com/post/breaking-zepbound-savings-card-2025-released-what-you-need-to-know
13. healthinsurance.org. Does health insurance cover drugs used for weight loss such as Ozempic, Wegovy, Mounjaro and Zepbound (Medicare GLP-1 Bridge, $50 a month, July 1, 2026 to December 31, 2027). https://www.healthinsurance.org/faqs/does-health-insurance-cover-drugs-used-for-weight-loss-such-as-ozempic-wegovy-mounjaro-and-zepbound/
14. GoodRx. Zepbound prices (KwikPen as low as $299 against an average retail price of $600.38), seen September 5, 2026. https://www.goodrx.com/zepbound
15. PrescriberPoint. Zepbound Savings Card, covered benefit terms ($25; $100/$200/$300 caps; $1,300; 13 fills; expires December 31, 2026), seen September 5, 2026. https://prescriberpoint.com/therapies/zepbound-487cd7e/financial-assistance/zepbound-savings-card---covered-benefit
16. FormBlends. Compounded GLP-1 Price Index, weekly snapshot as of September 3, 2026 (USD per 28-day supply, all-in cash, new U.S. self-pay patient). https://formblends.com/feeds/glp1-prices.json

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. LillyDirect is a service of Eli Lilly. GoodRx is a trademark of GoodRx Holdings. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.